This report was recently updated on December 19 2024 with the latest and most recent
market numbers
Global Nanocapsules Market Size, Trends & Analysis - Forecasts to 2026 By Application (Healthcare, Food & Nutraceuticals, Cosmetics, Agricultural Production and Others), By Therapy Area (Oncology, Pain Management, Endocrinology, and Others), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
Nanocapsules is a modern field of pharmacology that corresponds with numerous nanomedicine functions. Nanocapsules are drug discovery agents that vary in size from 10nm to 1000nm and are usually made up of a capsule shell and a void cavity in which the target material or drug compounds are stored. Globally, the introduction of effective and advanced technologies, as well as the proliferating end-user demand, are the primary growth triggers of the global nanocapsules market. Investments and scientific discoveries in biomedical, medicinal, electronics, molecular, and therapeutic fields are also key growth drivers. Furthermore, expanding use of nanocapsules for higher infection burdens such as tuberculosis and cancer, as well as developing economies including China, India, and many others, would provide new prospects for the global nanocapsules market.
The increasing prevalence of chronic diseases around the world has generated a need for new and efficient drug discovery mechanisms which is capable of supplying the requisite amount of medications at the site of operation at a given time. Nanocapsules are said to produce substantial outcomes while minimizing adverse effects. Thus, the global nanocapsules market will witness skyrocketing demand. Nevertheless, the rising cost of research & development activities, the complicated production process, and the growing cost of nanocapsules are the major constraints for the global Nanocapsules industry.
It has been estimated by research organizations that the utilization of nanocapsules will eliminate the usage of at least 50% of medicines that are being used for malignant diseases as it will avoid the other side effects that are possible from conventional medicines. Even food industries are incorporating the use of nanocapsules in their business, which will increase the market for nanocapsules by at least 10%. The market's optimistic growth is due to increasing spending by many firms on research and commodification programs. Certain goods have now been successfully commercialised in certain countries.
The utilization of nanocapsules in the pharmaceutical sector and food industry has been proved to be one of the major driving factors for the nanocapsule market. Various industries involved in the business of nanoparticle materials are increasing their research capabilities in order to produce and supply their nanocapsule in the market. Increasing use in research for cancer treatment is potentially fuelling up the market. The high cost of manufacturing setup is acting as a potential restraint for the growth of this market.
Coherent research and development programmes in the general area of nanotechnology would undoubtedly support this industry, offering a variety of prospects through numerous industries. One of the most notable benefits of nanocapsules is their potential to distribute unique active substances to particular areas (targeted drug delivery). Consequently, other benefits have pyrophoric and accelerated oxidation properties. These attributes pose a plethora of problems and opportunities for the production and commercialization of new and updated therapies.
Based on application, nanocapsules can be segregated into healthcare, food & nutraceuticals, cosmetics, agricultural production, and others. Healthcare is presumed to predominate in this market. One of the main usage segments for nanocapsules is healthcare, in which the technique is used in a variety of features and capabilities including drug discovery, regenerative medicine, diagnostic imaging nanomachines, and others. Currently, extensive research support, particularly from a number of developing countries, will help in leveraging the possible application of nanocapsules and make the healthcare segment lead.
Based on therapy area, nanocapsules can be segregated into oncology, pain management, endocrinology, and others. Oncology is likely to predominate in this market. Naocapsules are successful cancer-fighting drugs that hold a large number of anti-cancer compounds and successfully inject them into tumour cells. The number of cancer cases around the world has prompted researchers to become increasingly interested in designing new approaches to monitor the occurrence rates, while applying innovative methods to counteract its impacts which leads to the supremacy of oncology segment.
The nanocapsules market by region can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central & South America. North America leads the global nanocapsule market. The demand for nanocapsules in North America is the largest in the world. The majority of the combined share is accounted for by North America and Europe. This rise can be due to increased spending and research emphasis by strongly developed economies, including the United States and Germany. This is also due to the investment efforts centred on the advancement of new and highly successful advanced therapies including the use of nanocapsules. Due to the growing prospects for bioscience applications of nanocapsules, Asia Pacific is projected to manifest a profitable growth rate throughout the forecast period. Japan, as a developed economy, is associated with using these materials in a variety of applications such as fertilizers & pesticides, genetic engineering, cosmetics, and others. China and India are undertaking academic activities as well as numerous workshops, seminars, and conferences to discuss the requirement for novel enhanced therapies in order to capitalise on undiscovered demand opportunities and accelerate economic power in the near future.
BioDelivery Sciences, Camurus, Capsulation, Carlina Technologies, Cerulean Pharma Inc., Encap, Indian Instruments Manufacturing Company, L’Oreal, NanoNutra, NanoSphere Health Science, NoCamels, PlasmaChem GmbH, Sanzyme Ltd. And Sintef, among others, are the top players in the nanocapsules market.
Please note: This is not an exhaustive list of companies profiled in the report.
Delta 9 signed a licencing agreement with Nanosphere Health Sciences in 2021. This collaboration will transform the medicinal use of cannabis in Canada and around the world, and it will also have significant applications in the recreational market. Owing to the fact that Nanosphere is a nano-biotechnology organisation focusing on delivering dietary elements and medicines in the next decade. The proprietary NanoSphere Delivery SystemTM platform technology of the firm solves the issues of poor bioactivity and disproportionate dose levels of a wide variety of bioactive components, particularly cannabinoids. This system is the primary functional constitute in this agreement.
Chapter 1 Methodology
1.1 Market Scope & Definitions
1.2 Estimates & Forecast Calculation
1.3 Historical Data Overview And Validation
1.4 Data Sources
1.4.1 Secondary
1.4.2 Primary
Chapter 2 Report Outlook
2.1 Nanocapsules Market Overview, 2016-2026
2.1.1 Industry Overview
2.1.2 Application Overview
2.1.3 Therapy Area Overview
2.1.4 Regional Overview
Chapter 3 Nanocapsules Market Trends
3.1 Market Segmentation
3.2 Industry Background, 2016-2026
3.3 Market Key Trends
3.3.1 Positive Trends
3.3.1.1 Utilization of Nanocapsules in Pharmaceutical Sector
and Food Industry
3.3.1.2 Increasing Use in The Research for Cancer Treatment
3.3.2 Industry Challenges
3.3.2.1 High Cost of Manufacturing Set Up
3.4 Prospective Growth Scenario
3.4.1 Application Growth Scenario
3.4.2 Therapy Area Growth Scenario
3.5 COVID-19 Influence over Industry Growth
3.6 Porter’s Analysis
3.7 PESTEL Analysis
3.8 Value Chain & Supply Chain Analysis
3.9 Regulatory Framework
3.9.1 North America
3.9.2 Europe
3.9.3 APAC
3.9.4 LATAM
3.9.5 MEA
3.10 Technology Overview
3.11 Market Share Analysis, 2020
3.11.1 Company Positioning Overview, 2020
Chapter 4 Nanocapsules Market, By Application
4.1 Application Outlook
4.2 Healthcare
4.2.1 Market Size, By Region, 2016-2026 (USD Million)
4.3 Food & Nutraceuticals
4.3.1 Market Size, By Region, 2016-2026 (USD Million)
4.4 Cosmetics
4.4.1 Market Size, By Region, 2016-2026 (USD Million)
4.5 Agricultural Production
4.5.1 Market Size, By Region, 2016-2026 (USD Million)
4.6 Others
4.6.1 Market Size, By Region, 2016-2026 (USD Million)
Chapter 5 Nanocapsules Market, By Therapy Area
5.1 Therapy Area Outlook
5.2 Oncology
5.2.1 Market Size, By Region, 2016-2026 (USD Million)
5.3 Pain Management
5.3.1 Market Size, By Region, 2016-2026 (USD Million)
5.4 Endocrinology
5.4.1 Market Size, By Region, 2016-2026 (USD Million)
5.5 Others
5.5.1 Market Size, By Region, 2016-2026 (USD Million)
Chapter 6 Nanocapsules Market, By Region
6.1 Regional outlook
6.2 North America
6.2.1 Market Size, By Country 2016-2026 (USD Million)
6.2.2 Market Size, By Application, 2016-2026 (USD Million)
6.2.3 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.2.4 U.S.
6.2.4.1 Market Size, By Application, 2016-2026 (USD Million)
6.2.4.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.2.5 Canada
6.2.5.1 Market Size, By Application, 2016-2026 (USD Million)
6.2.5.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3 Europe
6.3.1 Market Size, By Country 2016-2026 (USD Million)
6.3.2 Market Size, By Application, 2016-2026 (USD Million)
6.3.3 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.4 Germany
6.3.4.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.4.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.5 UK
6.3.5.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.5.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.6 France
6.3.6.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.6.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.7 Italy
6.3.7.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.7.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.8 Spain
6.3.8.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.8.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.3.9 Russia
6.3.9.1 Market Size, By Application, 2016-2026 (USD Million)
6.3.9.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.4 Asia Pacific
6.4.1 Market Size, By Country 2016-2026 (USD Million)
6.4.2 Market Size, By Application, 2016-2026 (USD Million)
6.4.3 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.4.4 China
6.4.4.1 Market Size, By Application, 2016-2026 (USD Million)
6.4.4.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.4.5 India
6.4.5.1 Market Size, By Application, 2016-2026 (USD Million)
6.4.5.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.4.6 Japan
6.4.6.1 Market Size, By Application, 2016-2026 (USD Million)
6.4.6.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.4.7 Australia
6.4.7.1 Market Size, By Application, 2016-2026 (USD Million)
6.4.7.2 Market size, By Therapy Area, 2016-2026 (USD Million)
6.4.8 South Korea
6.4.8.1 Market Size, By Application, 2016-2026 (USD Million)
6.4.8.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.5 Latin America
6.5.1 Market Size, By Country 2016-2026 (USD Million)
6.5.2 Market Size, By Application, 2016-2026 (USD Million)
6.5.3 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.5.4 Brazil
6.5.4.1 Market Size, By Application, 2016-2026 (USD Million)
6.5.4.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.5.5 Mexico
6.5.5.1 Market Size, By Application, 2016-2026 (USD Million)
6.5.5.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.5.6 Argentina
6.5.6.1 Market Size, By Application, 2016-2026 (USD Million)
6.5.6.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.6 MEA
6.6.1 Market Size, By Country 2016-2026 (USD Million)
6.6.2 Market Size, By Application, 2016-2026 (USD Million)
6.6.3 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Market Size, By Application, 2016-2026 (USD Million)
6.6.4.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.6.5 UAE
6.6.5.1 Market Size, By Application, 2016-2026 (USD Million)
6.6.5.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
6.6.6 South Africa
6.6.6.1 Market Size, By Application, 2016-2026 (USD Million)
6.6.6.2 Market Size, By Therapy Area, 2016-2026 (USD Million)
Chapter 7 Company Landscape
7.1 Competitive Analysis, 2020
7.2 BioDelivery Sciences
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Strategic Positioning
7.2.4 Info Graphic Analysis
7.3 Camurus
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Strategic Positioning
7.3.4 Info Graphic Analysis
7.4 Capsulation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Strategic Positioning
7.4.4 Info Graphic Analysis
7.5 Carlina Technologies
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Strategic Positioning
7.5.4 Info Graphic Analysis
7.6 Cerulean Pharma Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Strategic Positioning
7.6.4 Info Graphic Analysis
7.7 Encap
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Strategic Positioning
7.7.4 Info Graphic Analysis
7.8 Indian Instruments Manufacturing Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Strategic Positioning
7.8.4 Info Graphic Analysis
7.9 L’Oreal
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Strategic Positioning
7.9.4 Info Graphic Analysis
7.10 NanoNutra
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Strategic Positioning
7.10.4 Info Graphic Analysis
7.11 NanoSphere Health Science
7.11.1 Company Overview
7.11.2 Financial Analysis
7.11.3 Strategic Positioning
7.11.4 Info Graphic Analysis
7.12 NoCamels
7.12.1 Company Overview
7.12.2 Financial Analysis
7.12.3 Strategic Positioning
7.12.4 Info Graphic Analysis
7.13 PlasmaChem GmbH
7.13.1 Company Overview
7.13.2 Financial Analysis
7.13.3 Strategic Positioning
7.13.4 Info Graphic Analysis
7.14 Sanzyme Ltd.
7.14.1 Company Overview
7.14.2 Financial Analysis
7.14.3 Strategic Positioning
7.14.4 Info Graphic Analysis
7.15 Sintef
7.15.1 Company Overview
7.15.2 Financial Analysis
7.15.3 Strategic Positioning
7.15.4 Info Graphic Analysis
7.16 Other Companies
7.16.1 Company Overview
7.16.2 Financial Analysis
7.16.3 Strategic Positioning
7.16.4 Info Graphic Analysis
The Global Nanocapsules Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Nanocapsules Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
